Conference abstract · 23 Mar 2015
Conference abstractPublished 24 Jun 2014
Bone marrow derived mesenchymal stem cells transplantation as a potential therapy for experimental epilepsy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
E pilepsy affects 0.5-1% of the world?s population, relatively large proportion of patients with temporal lobe epilepsy (TLE) are resistant to antiepileptic drugs or experience debilitating side effects from long-term treatment such as cognitive impairment, depression, or dementia. Novel approaches based on stem cell therapy offer the potential for curing epilepsy, rather than treating the symptoms. Given their ability to proliferate, differentiate and regenerate tissues, bone marrow derived mesenchymal stem cells (BMSCs) could restore neural circuits lost during the course of the disease and re-establish the physiological excitability of neurons. Aim of the study is to verify the therapeutic potential of (BMSCs) transplanted either intravenously (IV) or intracranially (IC) on experimentally induced temboral lobe epilepsy in rats. TLE was induced by a single dose of pilocarpine nitrate injected intraperitoneally. Rats were divided into four groups: 1) control group 2) epileptic group 3) IV injected BMSCs group and 4) IC injected BMSCs group. Oxidative stress, proinflammatory cytokines, neurotransmitters,immunohistochemical assay for Insulin growth factor receptor-1, synaptophysin and caspase-3 and histopathological investigation were assessed. BMCs effectively decreased lipid peroxides, TNF-α, IL-1β and glutamate level in both cortex and hippocampus, also a significant decrease in the level of each of IGF-1R, Synaptophysin and caspase -3 was regarded in BMCs - treated rats. Moreover histopathological examination illustrated mature neural cells with prominent granules. It is worth noting, IC transplantation showed to be more effective than IV transplantation. The data demonstrate that BMCs transplantation has potent therapeutic effects and could be a potential therapy for clinically intractable epilepsies
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Jun 2014
Bone marrow-derived autologous mesenchymal stem cells for therapy of type 2 diabetes mellitus patients’ tertiary failure
Review article · 2017
Into the Eyes of Bone Marrow-Derived Mesenchymal Stem Cells Therapy for Myocardial Infarction and Other Diseases
Conference abstract · 2015
Neuron point-of-care stem cell therapy (N-POCST): Transplantation of autologous bone marrow derived stemcells for traumatic central nervous system disorders, the future of a new method
Conference abstract · 29 Feb 2016
The therapeutic role of the bone marrow mesenchymal stem cells and the schwann cells and their co-transplantation in regeneration of the injured sciatic nerve in rats
More from this journal
The newest in Journal of Cell Science & Therapy.
Perspective · 2 Feb 2026
Exploring Senescence and Its Influence on Tissue Function and Therapeutic Research
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Neveen A Salem”
- BylineArticles whose byline prints “Yasser A Khadrawy”
- BylineArticles whose byline prints “Marwa E El Shamarka”

